1. Postgraduate training in Cancer Genetics-a cross-specialty survey exploring experience of clinicians in Ireland
- Author
-
Nazmy El Beltagi, Gozie Offiah, Seamus O'Reilly, Terri P. McVeigh, Sean Daly, Michael Kevin Barry, and Jana K McHugh
- Subjects
medicine.medical_specialty ,Specialty ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Obstetrics and gynaecology ,Pregnancy ,Neoplasms ,Surveys and Questionnaires ,Cancer Genetics ,Medicine ,Humans ,030212 general & internal medicine ,Estimation ,business.industry ,Mainstreaming Genetic Testing ,Cancer ,General Medicine ,Genomics ,medicine.disease ,Cross-Sectional Studies ,Education, Medical, Graduate ,Postgraduate Medical Education ,Cancer genetics ,Family medicine ,Cohort ,Female ,Original Article ,Personalized medicine ,Postgraduate training ,business ,Ireland - Abstract
Background As genomic profiling of constitutional and tumour-derived DNA becomes increasingly critical in cancer risk estimation, prognostication and treatment, there is a growing need for clinicians involved in cancer care to up-skill in Cancer Genetics. In the Republic of Ireland (ROI), this is particularly crucial, given a paucity of vocationally trained Clinical Geneticists per capita compared to other European countries. Aims We aimed to assess the self-reported confidence of postgraduate medical/surgical trainees in ROI in requesting, interpreting, and managing genomic data in patients with cancer, and to assess their selfreported experience, and demand for future training in this area. Methods A cross-sectional survey of postgraduate trainees in four specialties (Medical and Radiation Oncology, Surgery, and Obstetrics and Gynaecology (O&G)), training in ROI, was undertaken. A bespoke electronic questionnaire was designed to capture data regarding preceding experience, and confidence across several hypothetical clinical scenarios involving genomic testing. The survey was circulated to eligible participants by training programme administrators, after relevant institutional ethical approval. Data was collected anonymously. Results The study cohort included 62 respondents. A paucity of cancer genetics training at every level was demonstrated, with “hardly any” or “none at all” reported by 47(76%), 62(100%), and 50(81%) during undergraduate, core specialty, and higher specialist training, respectively. A relative lack of confidence in all clinical scenarios was apparent, particularly among Surgery/O&G trainees. Most respondents would value more training in Cancer Genetics. Conclusions This study demonstrates an unmet need in dedicated Cancer Genetics training for postgraduate specialty trainees in ROI.
- Published
- 2021